GE Healthcare climbs after better-than-expected quarterly results

** Shares of medical device maker GE Healthcare (GEHC.O) rise 10.8% to $71 premarket

** Co reports Q2 adj. EPS of $1.13, above analysts' avg. estimate of $1.04/share - LSEG data

** Co posts Q2 sales of $5.30 bln, above expectations of $5.26 bln

** On patient care solutions, CEO Peter Arduini says co is focused on returning the business to growth and profitability, while reviewing strategic options to maximize its long-term value

** "Global geopolitical instability, including the conflict in the Middle East, adversely impacted our costs, supply chains, and logistics during the second quarter of 2026" - GEHC regulatory filing

** As of last close, stock down 21.8% YTD